Remove Food and Drug Administration Remove Healthcare Remove Networking Remove Prescription
article thumbnail

Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants

Legacy MEDSearch

Food and Drug Administration (“FDA”) of BabySat , the first medical pulse-oximetry device featuring its advanced, wire-free sock design. Innovation in the baby care space matters because some of the largest issues facing caregivers and healthcare providers have yet to be solved. To learn more, visit www.owletcare.com.

article thumbnail

FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor

Legacy MEDSearch

Food and Drug Administration (FDA) announced the clearance of Dexcom’s device, marking it as the first continuous glucose monitor available over the counter. Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. On March 5, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. Professional Advertising: Professional advertising, also known as Direct-to-Professional (DTP) advertising, is another type of pharmaceutical advertising that is aimed at healthcare professionals such as doctors, nurses, and pharmacists.

Pharma 52
article thumbnail

HeartBeam Announces Acquisition of LIVMOR Assets

Legacy MEDSearch

Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. LIVMOR’s technology was commercially deployed within the VA Healthcare System in Dallas, Texas. HeartBeam CEO and Founder. About HeartBeam, Inc.

article thumbnail

First Light Field-Enabled Spine Surgery Navigation Platform, Proprio Paradigm™, Receives FDA Clearance

Legacy MEDSearch

Food and Drug Administration (FDA). Proprio’s goal is to dramatically improve clinical and economic outcomes by unlocking both the ability to capture advanced data and the potential of that data to inform more predictive and prescriptive intelligence in surgery.

FDA 52
article thumbnail

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke

Legacy MEDSearch

Food and Drug Administration (FDA). This important milestone enables the world’s first prescription music platform, and is a remarkable day for our company, for music, for healthcare, and most importantly for stroke survivors.”

FDA 52
article thumbnail

Pharma within planetary boundaries

European Pharmaceutical Review

2 A study found that pharmaceuticals and other chemical products are responsible for 40 percent of the Dutch healthcare system’s greenhouse gas emissions and about 80 percent of its share of material extraction. The environmental impact of the Dutch healthcare sector beyond climate change: an input-output analysis. 2022; 6: 949-57.

Pharma 79